Best Cheap Stocks For 2019: July 2014

Thursday, July 31, 2014

Best Net Payout Yield Companies To Invest In 2015

Best Net Payout Yield Companies To Invest In 2015: Molex Incorporated(MOLX)

Molex Incorporated, together with its subsidiaries, engages in the design, manufacture, and sale of electronic components worldwide. It offers micro-miniature connectors, B-to-B connectors, SIM and SD card sockets, keypads, electromechanical subassemblies, internal and on-ground antennas, standard antennas, magnetic jacks, and subsystems for the telecommunications market; and power, optical, and signal connectors and cables for end-to-end data transfer, linking disk drives, controllers, servers, switches, and storage enclosures for the info-tech market. The company also designs and manufactures connectors for home and portable audio, digital still and video cameras, DVD players, and recorders, as well as devices that combine multiple functions in the consumer market, earphones, jumpers, and components for gaming machines. In addition, it provides network interface cards, software for industrial networks, cord sets, electrical solutions, and I/O connectors for industrial pr oduction equipment, as well as portable lighting to power distribution solutions for commercial construction, utility, petrochemical, and food and beverage industries; and cable assemblies, sealed and panel mount connectors, and other products for use in the infotainment and navigation, powertrain, safety and chassis, and body electronics in the automotive market. Further, the company offers connectors and custom integrated systems for diagnostic and therapeutic equipment used in hospitals, including x-ray, magnetic resonance imaging, and dialysis machines; and solid-state lighting products. Additionally, it provides manufacturing services to integrate specific components into a customer?s product. The company sells its products directly to original equipment manufacturers, contract manufacturers, and distributors. It markets its products through direct sales force and a network of distributors. Molex Incorporated was founded in 1938 and is based ! in Lisle, Illinois.

Advisors' Opinion:

[By Diane Alter]
Koch Industries, one of the largest private companies in the United States, announced Monday it will buy electronic components manufacturer Molex Inc. (Nasdaq: MOLX) for $7.2 billion.
[By Alexis Xydias]
Molex (MOLX) soared 32 percent to $38.63 for the largest increase in the S&P 500. The maker of electronic components for products such as Apples iPhone agreed to a $7.2 billion acquisition by Koch Industries, the holding company controlled by the billionaire Koch brothers.
[By Paul Ausick]
Stocks on the move: Delta Air Lines Inc. (NYSE: DAL) is up 9.3% at $21.74 after being adding to the S&P 500 index. BlackBerry Ltd. (NASDAQ: BBRY) is up 6.4% at $11.53 on reports that a former board member has nearly lined up financing to take the company private. Molex Inc. (NASDAQ: MOLX) is up 31.6% at $38.60 following an agreement to be acquired by Koch Industries Inc.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-net-payout-yield-companies-to-invest-in-2015.html

5 Best Growth Stocks To Watch For 2014

Advisors who have watched the disruption ETFs brought about in their early days, and their explosive growth since, may be wondering if a market that in 2013 reached past $1 trillion in assets is now ready to slow down.

“Indexing has not run its course. We’re just in the third inning,” comes the reply from Nasdaq’s John Jacobs, who, in a highly-caffeinated phone interview with ThinkAdvisor, embodied the notion that ETFs won’t be slowing down if he’s in a position to do anything about it.

And, as the head of the exchange’s information products division, which creates and licenses indexes, Jacobs offers a key position in the ETF universe. He also manages to keep busy.

“Two years ago I had 2,000 products; today I have 41,000. We rolled out 13,000 last week [in the global equities space],” says Jacobs.

So what does he see, from his perch atop the Nasdaq, that gives him confidence we’re just a third of the way through the game?

10 Best Retail Stocks To Buy For 2015: MEDIFAST INC(MED)

Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.

Advisors' Opinion:

[By Holly LaFon] ast produces, distributes and sells weight and health management products with the brand names Medifast, Take Shape for Life, Hi-Energy Weight Control Centers and Woman�� Wellbeing.
Its return on assets in the third quarter of 2011 was 19.6%, which has been increasing in the past several years. The average return on assets for the specialty retail industry is 10.48% for the trailing 12 months.
The company�� total assets amounted to $94 million in 2010, which increased from $62.8 million in 2009. Net income also increased to $19.6 million in 2010 from $12 million in 2009.
Boston Beer Inc. (SAM)
Boston Beer Inc. is the largest brewer of handcrafted beers in America. Boston Beer is a growing company that recently saw a large increase in its return on assets. It increased from 19.3% in 2010 to 29.7% in 2011, and was negative as recently as 2008. The average return on assets for the beverages industry in the trailing 12 months is 9.47%.
In 2011, the company�� total assets increased to $272.5 million from $258.5 million in 2010. Net income increased to $66 million from $50 million.
Alliances Resources Partners (ARLP)
Alliance Resources Partners is a coal producer and marketer primarily in the eastern U.S. Its ROA has been increasing since 2008 and increased to 22.5% in 2011 from 21.4% in 2010. The average return on assets for the oil, gas & consumable fuels industry in the trailing 12 months is 24.47%.
In 2011, its total assets increased to $1.7 billion from $1.1 billion in 2010. Its net income increased to $389 million from $321 million.
Factset Research Systems Inc. (FDS)
Factset researches global market trends and develops analytical tools for investors. Of all of GuruFocus��5-star predictable companies, it has the highest return on assets at 27%. ROA has been increasing over the past several years. The average return on assets for the software industry for the trailing 12 m
[By Jon C. Ogg]
Medifast Inc. (NYSE: MED) saw its stock down 5% in evening trading on Tuesday after the weight loss player had soft sales and guided expectations lower. Shares were still indicated down about 5%, but volume has not yet started.
[By Monica Gerson]
Medifast (NYSE: MED) is expected to post its Q4 earnings at $0.36 per share on revenue of $80.83 million.

Full House Resorts (NASDAQ: FLL) is estimated to post a Q4 loss at $0.06 per share on revenue of $33.24 million.

5 Best Growth Stocks To Watch For 2014: Checkpoint Systms Inc.(CKP)

Checkpoint Systems, Inc. manufactures and markets identification, tracking, security, and merchandising solutions for the retail and apparel industry worldwide. The company operates in three segments: Shrink Management Solutions, Apparel Labeling Solutions, and Retail Merchandising Solutions. The Shrink Management Solutions segment provides shrink management and merchandise visibility solutions. It offers electronic article surveillance systems, such as EVOLVE, a suite of RF and RFID-enabled products that act as a deterrent to prevent merchandise theft in retail stores; and electronic article surveillance consumables, including EAS-RF and EAS-EM labels that work in combination with EAS systems to reduce merchandise theft in retail stores. This segment also provides keepers, spider wraps, bottle security, and hard tags, as well as Showsafe, a line alarm system for protecting display merchandise. In addition, it offers physical and electronic store monitoring solutions, incl uding fire alarms, intrusion alarms, and digital video recording systems for retail environments; and RFID tags and labels. The Apparel Labeling Solutions segment provides apparel labeling solutions to apparel retailers, brand owners, and manufacturers. It has Web-enabled apparel labeling solutions platform and network of 28 service bureaus located in 22 countries that supplies customers with customized apparel tags and labels. The Retail Merchandising Solutions segment offers hand-held label applicators and tags, promotional displays, and queuing systems. The company serves retailers in the supermarket, drug store, hypermarket, and mass merchandiser markets through direct distribution and reseller channels. Checkpoint Systems was founded in 1969 and is based in Thorofare, New Jersey.

Advisors' Opinion:

[By Rich Smith]
Three months after settling upon a new chief executive officer, it looks like Thorofare, N. J.-based Checkpoint Systems (NYSE: CKP ) will soon have itself a new CFO as well.
[By John Udovich]
Small cap Checkpoint Systems, Inc (NYSE: CKP) fights shoplifting or retail theft and other forms of�"shrink��that costs retailers over $112 billion worldwide last year (according to a study funded by the company), meaning it might be an interesting stock to take a closer look at and to compare its performance with that of SPDR S&P Retail ETF (NYSEARCA: XRT) and PowerShares Dynamic Retail ETF (NYSEARCA: PMR). Just how bad can shoplifting or shrink be for a retailer? Troubled retailer J.C. Penney Company, Inc (NYSE: JCP) has just reported that shoplifting took a full percentage point off the department store chain's profit margins during the quarter. Moreover and given that tens of millions of Americans are now facing higher health insurance costs thanks to Obamacare (which will likely impact consumer discretionary spending),�retailers�will need to find ways to shore up their margins and bottom lines by preventing�retail theft with solutions from company�� like Checkpoint Systems.
[By Lisa Levin]
Checkpoint Systems (NYSE: CKP) surged 17.73% to $14.21. The volume of Checkpoint Systems shares traded was 525% higher than normal. Checkpoint announced its intent to extend the filing date of its annual report.

5 Best Growth Stocks To Watch For 2014: Delphi Financial Group Inc. (DFG)

Delphi Financial Group, Inc., together with its subsidiaries, provides integrated employee benefit services. The company operates in two segments, Group Employee Benefit Products and Asset Accumulation Products. The Group Employee Benefit Products segment provides disability, group life, and excess workers? compensation insurance products to small and mid-sized employers. It also offers travel accident, voluntary accidental death and dismemberment, group dental, and limited benefit health insurance products, as well as assumed workers? compensation and casualty reinsurance. This segment markets its group products to employer-employee groups and associations in various industries primarily through independent brokers and agents. The Asset Accumulation Products segment primarily offers fixed annuities, such as single premium deferred annuities, flexible premium annuities, and multi-year interest guarantee products to individuals through networks of independent insurance agen ts. The company also provides integrated disability and absence management services, including event reporting, leave of absence management, claims and case management, and return to work management. Delphi Financial Group, Inc. was founded in 1987 and is based in Wilmington, Delaware.

Advisors' Opinion:

[By Holly LaFon]
Some of Elliott Management�� top equity positions in the first quarter 2012 are Brocade Communications Systems (BRCD), Delphi Automotive (DFG), Iron Mountain (IRM) and News Corp. (NWS).

5 Best Growth Stocks To Watch For 2014: Nordstrom Inc.(JWN)

Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for women, men, and children in the United States. It offers a selection of brand name and private label merchandise. The company sells its products through various channels, including Nordstrom full-line stores, off-price Nordstrom Rack stores, Jeffrey? boutiques, treasure & bond, and Last Chance clearance stores; and its online store, nordstrom.com, as well as through catalog. Nordstrom also provides a private label card, two Nordstrom VISA credit cards, and a debit card for Nordstrom purchases. The company?s credit and debit cards feature a shopping-based loyalty program. As of September 30, 2011, it operated 222 stores, including 117 full-line stores, 101 Nordstrom Racks, 2 Jeffrey boutiques, 1 treasure & bond store, and 1 clearance store in 30 states. The company was founded in 1901 and is based in Seattle, Washington.

Advisors' Opinion:

[By Will Ashworth]
In the same period, Nordstrom (JWN) has seen net income increase by 83% on a 46% jump in revenue. True, Nordstrom is luxury while Kohl’s isn’t, but Mansell has a lot of work regardless to do if he wants Kohl�� to even be in the same league as Nordstrom from an operational standpoint.

Wednesday, July 30, 2014

10 Best Warren Buffett Stocks To Watch For 2014

Berkshire Hathaway Inc. (NYSE: BRK-B) and Warren Buffett disclosed their full equity holdings this week. The first thing we noticed was that there was a total equity value of $92.035 billion at the end of September, versus $89.03 billion at the end of June. What stood out was that there were really only about five transactions that really mattered . Still, they offer great insight and opportunity.

24/7 Wall St. wanted to identify the most important Buffett transactions of the past quarter. We wanted to see what the expected value is ahead for individual investors who may want to copy the Oracle of Omaha’s strategy. We also wanted to get inside Mr. Buffett’s head to see what he was thinking and how our readers can benefit.

The most important change was one we have called for endlessly, and we joked that Buffett finally took our suggestion. This was a new stake of Exxon Mobil Corp. (NYSE: XOM) with almost 40.1 million shares. We just outlined the 10 reasons he took such a big stake, and we would say that it seems likely that Team Buffett would only grow this stake through time. Shares were up yet another 1% on Friday trading to above $94.00, and the consensus analyst price target is $95.54. Note that some analysts see it rising to well over $100 in the year, or years, ahead. Buffett even made a statement in favor of Exxon, because he substantially lowered his stake in ConocoPhillips.

5 Best Diversified Bank Stocks To Own Right Now: World Fuel Services Corporation (INT)

World Fuel Services Corporation, a fuel logistics company, engages in marketing, selling, and distributing aviation, marine, and land fuel products and related services worldwide. The company operates in three segments: Aviation, Marine, and Land. The Aviation segment offers fuel and related services to commercial airlines, second and third-tier airlines, cargo carriers, regional and low cost carriers, airports, fixed based operators, corporate fleets, fractional operators, private aircraft, military fleets, and to the U.S. and foreign governments. Its aviation related services include fuel management, price risk management, arranging ground handling, and dispatch services; and arranging and providing international trip planning, including flight plans, weather reports, and overflight permits. The Marine segment offers fuel and related services to international container and tanker fleets, commercial cruise lines, yachts, and time-charter operators, as well as to the U.S. and foreign governments. Its marine fuel related services comprise management services for the procurement of fuel, cost control, quality control, and claims management. This segment also provides various services, which consist of fueling of vessels in port and sea, and transportation and delivery of fuel and fuel products. The Land segment offers fuel and related services to petroleum distributors operating in the land transportation market; retail petroleum operators; and industrial, commercial, and government customers, as well as engages in crude oil marketing activities. Its land related services include management services for the procurement of fuel and price risk management. In addition, the company offers transaction management services, which consists of card payment solutions and merchant processing services to customers in the aviation, marine, and land transportation industries. World Fuel Services Corporation was founded in 1984 and is headquartered in Miami, Florida.

Advisors' Opinion:

[By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, fuel logistics company World Fuel Services (NYSE: INT ) has earned a coveted five-star ranking.

10 Best Warren Buffett Stocks To Watch For 2014: Isramco Inc.(ISRL)

Isramco, Inc., together with its subsidiaries, engages in the acquisition, development, production, and exploration of onshore oil and natural gas properties in the United States. It owns various working interests in oil and gas wells in Louisiana, Texas, New Mexico, Oklahoma, Wyoming, Utah, and Colorado; and operates approximately 589 wells principally in Texas and New Mexico. The company sells its oil and natural gas products to independent marketers, oil and natural gas companies, and gas pipeline companies. As of December 31, 2010, its estimated total proved reserves were approximately 9,031 thousand barrels of oil equivalent, which included 3,318 thousand barrels of oil, and 23,701 million cubic feet of natural gas, and 1,763 thousand barrels of natural gas liquids. The company was founded in 1982 and is based in Houston, Texas.

Advisors' Opinion:

[By Rich Duprey]
Yet when you think about it, there should be oil there. It's been found on all sides of Israel. Total� (NYSE: TOT ) �found�oil north of the Sinai Peninsula in the 1980s, but the wells subsequently went dry;�Isramco� (NASDAQ: ISRL ) found oil off the coast of Tel Aviv, but never enough to make it profitable; and�Noble found a large gas deposit in the Tamar field of the Levant basin. Several Israeli companies have also found oil and gas, but Zion keeps striking out.
[By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Isramco (Nasdaq: ISRL ) , whose recent revenue and earnings are plotted below.
[By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Isramco (Nasdaq: ISRL ) , whose recent revenue and earnings are plotted below.

10 Best Warren Buffett Stocks To Watch For 2014: MWI Veterinary Supply Inc.(MWIV)

MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.

Advisors' Opinion:

[By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on MWI Veterinary Supply (Nasdaq: MWIV ) , whose recent revenue and earnings are plotted below.
[By Rupert Hargreaves]
Pet-related companies are highly sought after
Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis -- greater demand for animal treatments will lead to more demand for the distribution of animal health products.
[By Ben Levisohn]
Overvalued companies include MWI Veterinary (MWIV) and�Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls�Aratana (PETX) a “hidden gem.”

10 Best Warren Buffett Stocks To Watch For 2014: Document Security Systems Inc (DSS)

Document Security Systems, Inc. (DSS), incorporated on May 30, 1984, develops, markets, secure technologies. The Company specializes in fraud and counterfeit protection for all forms of printed documents and digital information. The Company holds numerous patents for optical deterrent technologies that provide protection of printed information from unauthorized scanning and copying. The Company operates three production facilities, a security and commercial printing facility, a packaging facility and a plastic cards facility, where the Company produces secure and non-secure documents for its customers. The Company licenses its anti-counterfeiting technologies to printers and brand-owners. In addition, the Company has a digital division which provides cloud computing services for its customers, including disaster recovery, back-up and data security services. The Company operates in four segments: DSS Printing Group, DSS Plastics Group, DSS Packaging Group and DSS Digital Group. In June 2013, Document Security Systems Inc announced the closing of its previously announced merger with Lexington Technology Group, Inc. In October 2013, the Company announced that it has acquired two portfolios that will enable DSS to develop protected hardware and peripherals that incorporate core DSS security technologies.

The Company provides document security technology to security printers, corporations, consumer product companies and governments worldwide and for currency, identifications, certifications, travel documents, prescription and medical forms, consumer product and pharmaceutical packaging, and school transcripts. Its products are delivered on paper, plastic, or digitally via its AuthentiGuard DX product suite.

DSS Printing Group

The DSS Printing Group provides secure and commercial printing services for end-user customers along with technical support for the Company�� technology licensees. The division produces a wide array of printed materials such as security paper,! vital records, prescription paper, birth certificates, receipts, manuals, identification materials, entertainment tickets, secure coupons, parts tracking forms, brochures, direct mailing pieces, catalogs, business cards, etc. The division also provides the basis of research and development for its security printing technologies.

DSS Plastics Group

The DSS Plastics Group manufactures laminated and surface printed cards which can include magnetic stripes, bar codes, holograms, signature panels, invisible ink, micro fine printing, guilloche patterns, biometric, radio frequency identification (RFID) and watermarks for printed plastic documents such as identity cards, event badges, and driver�� licenses.

DSS Packaging Group

The DSS Packaging Group produces custom paperboard packaging serving clients in the pharmaceutical, beverage, photo packaging, toy, specialty foods and direct marketing industries, among others. The division incorporates the Company's security technologies into printed packaging to help companies prevent or deter brand and product counterfeiting.

DSS Digital Group

The DSS Digital Group provides data center centric solutions to businesses and governments delivered via the cloud. This division is also develops digital data security technologies based on the Company�� optical deterrent technologies.

The Company competes with Standard Register Company, De La Rue Plc, Sharp, Xerox Canon, Ricoh, Hewlett Packard, Eastman Kodak, NoCopi Technologies, Graphic Security Systems Corporation, RR Donnelley, Canadian printer Quebecor World, Bristol ID, AbNote, LaserCard Corporation and L-1 Identity Solutions, Rock-Tenn Company, Caraustar Industries, Inc., Graphic Packaging Holding Company and Mead Westvaco.

Advisors' Opinion:

[By Susan Decker]
Document Security Systems Inc. (DSS), based in Rochester, New York, is suing Facebook Inc. and LinkedIn Corp. for infringing technology covering online collaboration. The patents were acquired in a reverse merger with Lexington Technology Group Inc., an intellectual property company. The shares have fallen 33 percent since the deal closed on July 1.

10 Best Warren Buffett Stocks To Watch For 2014: Impala Platinum Holdings Ltd (IMPUY.PK)

Impala Platinum Holdings Limited (Implats) is a producer of platinum group metals (PGMs) and associated base metals. Implats has operations on the PGM-bearing orebodies of the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. PGMs include platinum, and the associated by-products, palladium, rhodium, ruthenium, iridium and gold usually occur in association with nickel and copper. As of June 30, 2012, the Company�� holdings in various mining and exploration activities included Impala Platinum Limited (100%), which includes PGM mining, processing and refining; Impala Refining Services Limited (100%), which is engaged in purchase of concentrate and/or smelter matte; Impala Chrome (Pty) Limited (100%) and Makgomo Chrome (Pty) Limited (50%), which are engaged in purchase of chrome in tailings, and Zimplats Holdings Limited (86.9%), Afplats (Pty) Limited (74%), Marula Platinum (Pty) Limited (73%), Mimosa Investments Limited (50%) and Two Rivers Platinum (Pty) Limited (45%), which are engaged in PGM mining.

Impala Platinum

Impala Platinum, Implats��primary operational unit, has operations situated on the Impala lease area on the western limb of the Bushveld Complex near Rustenburg in South Africa, and in Springs east of Johannesburg. Impala holds contiguous mining rights and prospecting rights for a total area of 260 square kilometres. Operations comprise 14 operational shaft systems, five of which have underground decline systems.

Zimplats Holdings Limited

Zimplats Holdings Limited (Zimplats) is 87% owned by Implats and is located on the Hartley Geological Complex on the Zimbabwean Great Dyke south-west of Harare. Zimplats operates three underground mines and a concentrator at Ngezi. The Selous Metallurgical Complex (SMC), located some 77 kilometer north of the mine, comprises a concentrator and a smelter. The Company also owns the Hartley Platinum Mine situated at the SMC, which is under care and maintenance.

Marula Platin! um Limited

Marula Platinum Limited (Marula) is 73% owned by Implats. Marula is located in the Limpopo Province, some 50 kilometres north of Burgersfort. The operation consists of two on-reef decline shafts, one off-reef conventional decline and a concentrator plant.

Mimosa

Mimosa is wholly owned by Mimosa Investments Limited, a Mauritius-based company jointly held by Implats and Aquarius Platinum Limited (Aquarius) in a 50:50 joint-venture. Mimosa is located on the Wedza Geological Complex on the Zimbabwean Great Dyke east of Bulawayo. The operation comprises a shallow underground mine, accessed by a decline shaft, and a concentrator.

The Two Rivers Platinum Mine

The Two Rivers Platinum Mine (Two Rivers) is a joint venture between African Rainbow Minerals (ARM) (55%) and Impala Platinum Holdings Limited (Implats) (45%). The operation is situated on the farm Dwarsrivier on the southern part of the eastern limb of the Bushveld Igneous Complex in Mpumalanga, South Africa. The operation consists of two on-reef decline shafts and a concentrator.

Impala Refining Services (IRS)

IRS products include flotation concentrates from Marula, Mimosa and Two Rivers, as well as Aquarius��Marikana, Everest mine and Blue Ridge mines (on care and maintenance) and Eastern Platinum�� Crocodile River mine; furnace matte from Zimplats; spent autocatalysts from A-1 Specialised Services and Supplies Inc. for recycling, and selected base metal residues and other secondary materials.

Advisors' Opinion:

[By Zacks Investment Research]
It is hard to find a good play in the Zacks Industry of mining non-ferrous metals, as the industry currently has a rank of 247 out of 261. In fact, in our five mining industries, there are only two No. 1-Ranked stocks: Brigus Gold (BRD) and Impala (IMPUY.PK). Both of these are in struggling industries, but they have proven to be best-in-class thanks to improving earnings estimates. Plus, both have seen their ranks surge from holds (or worse) up to strong buy territory, suggesting either of these names might be better picks than the struggling SCCO at this time.

10 Best Warren Buffett Stocks To Watch For 2014: PRGX Global Inc.(PRGX)

PRGX Global, Inc., together with its subsidiaries, provides recovery audit, healthcare claims recovery audit, and analytics and advisory services. The company?s recovery audit services are based on the mining and auditing of clients? purchasing data for overpayments to suppliers; and healthcare claims recovery audit services consist of identification of overpayments and underpayments made to healthcare providers, such as hospitals and physicians? practices. Its analytics and advisory services focuses on client functional and process areas and provides services to senior finance executives to optimize working capital, reduce enterprise costs, transform the finance function, and enhance corporate performance. The company serves retailers, such as discount, department, specialty, grocery, and drug stores; business enterprises, including manufacturers, financial services firms, and pharmaceutical companies; private sector health insurance companies, and state and federal go vernment payers consisting of the centers for Medicare and Medicaid Services; and federal and state government agencies. It has operations in the United States, Canada, rest of Latin America, Europe, Asia, and rest of the Pacific region. The company was formerly known as PRG-Schultz International, Inc. and changed its name to PRGX Global, Inc. in January 2010. PRGX Global, Inc. was founded in 1990 and is based in Atlanta, Georgia.

Advisors' Opinion:

[By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on PRGX Global (Nasdaq: PRGX ) , whose recent revenue and earnings are plotted below.

10 Best Warren Buffett Stocks To Watch For 2014: American Airlines Group Inc (AAL)

American Airlines Group Inc., formerly AMR Corporation, incorporated in October 1982, operates in the airline industry. The Company's principal subsidiary is American Airlines, Inc. (American). As of December 31, 2011, American provided scheduled jet service to approximately 160 destinations throughout North America, the Caribbean, Latin America, Europe and Asia. AMR Eagle Holding Corporation (AMR Eagle), a wholly owned subsidiary of the Company, owns two regional airlines, which do business as American Eagle-American Eagle Airlines, Inc. and Executive Airlines, Inc. (collectively, the American Eagle carriers). American also contracts with an independently owned regional airline, which does business as AmericanConnection (the AmericanConnection carrier). As of December 31, 2011, AMR Eagle operated approximately 1,500 daily departures, offering scheduled passenger service to over 175 destinations in North America, Mexico and the Caribbean.

American, AMR Eagle and the AmericanConnection airline served more than 250 cities in approximately 50 countries with, on average, 3,400 daily flights and the combined network fleet numbered approximately 900 aircraft as of December 31, 2011. American Airlines is also a founding member of the oneworld alliance, which includes British Airways, Cathay Pacific, Finnair, LAN Airlines, Iberia, Qantas, JAL, Malev Hungarian, Mexicana, Royal Jordanian and S7 Airlines. Together, oneworld members serve 750 destinations in approximately 150 countries, with about 8,500 daily departures. American is also one of the scheduled air freight carriers in the world, providing a range of freight and mail services to shippers throughout its system onboard American's passenger fleet.

To improve access to each other's markets, American has established marketing relationships with other airlines and rail companies. As of December 31, 2011, American had marketing relationships with Air Berlin, Air Pacific, Air Tahiti Nui, Alaska Airlines, British Airways, Cape Air, C! athay Pacific, China Eastern Airlines, Dragonair, Deutsche Bahn German Rail, EL AL, Etihad Airways, EVA Air, Finnair, GOL, Gulf Air, Hawaiian Airlines, Iberia, Japan Airlines (JAL), Jet Airways, JetStar Airways, LAN (includes LAN Airlines, LAN Argentina, LAN Ecuador and LAN Peru), Niki Airlines, Qantas Airways, Royal Jordanian, S7 Airlines, and Vietnam Airlines.

American has established the AAdvantage frequent flyer program (AAdvantage). AAdvantage members earn mileage credits by flying on American, American Eagle and the AmericanConnection carrier or by using services of other participants in the AAdvantage program. Mileage credits can be redeemed for free, discounted or upgraded travel on American, American Eagle or other participating airlines, or for other awards. American sells mileage credits and related services to other participants in the AAdvantage program. There are over 1,000 program participants, including a credit card issuer, hotels, car rental companies, and other products and services companies in the AAdvantage program. As of December 31, 2011, AAdvantage had approximately 69 million total members.

The Company competes with Alaska Airlines (Alaska), Delta Air Lines (Delta), Frontier Airlines, JetBlue Airways (JetBlue), Hawaiian Airlines, Southwest Airlines (Southwest) and AirTran Airways (Air Tran), Spirit Airlines, United Airlines (United) and Continental Airlines (Continental), US Airways and Virgin America Airlines.

Advisors' Opinion:

[By Ben Levisohn]
You can never let a little good news stand between you and your desire to sell. That seems to be the case for American Airlines (AAL) and Southwest Airlines (LUV) today, who’s solid revenue numbers have caused shares of these airlines–as well as Delta Air Lines (DAL) and United Continental (UAL) to fall today.
[By Chris Isidore and Gregory Wallace]
The new American Airlines trades on the Nasdaq under the symbol AAL (AAL). Most of the shares were distributed to AMR's former creditors and US Airways shareholders. But in an unusual step for a company emerging from bankruptcy, American's former shareholders got 0.0665 share of AAL stock for each of their former shares of AMR, giving them just over 3% of the company.

Tuesday, July 29, 2014

Invesco European Growth Fund Second Quarter 2014 Commentary

Performance SummaryAfter a brief pause in the first quarter, international equity markets moved higher, ending the second quarter of 2014 with positive absolute returns across the board. Canada and the UK were the best performing major markets, while both Europe excluding the UK and developed Asia lagged. Emerging markets also performed well as investors began to anticipate an end to negative earnings revisions. Overall, the world seems to be moving from a market driven by Central Bank actions, as evidenced by 2013's higher beta performance, to a market that focuses more on less volatile companies with durable earnings growth and trading at reasonable prices.Invesco European Growth Fund (Trades, Portfolio) Class A shares at net asset value (NAV) posted a return of 3.81% for the second quarter of 2014, outperforming the MSCI European Growth Index, which returned 2.86%.Stock selection in financials, industrials and health care drove relative outperformance. Having a meaningful overweight in energy, the quarter's strongest sector, compared to the index also added to relative return.Fund holdings in the financials, health care and industrials sectors outperformed those of the benchmark and were among the strongest contributors to relative performance.Shire PLC (LSE:SHP) and Haci Omer Sabanci Holding AS (IST:SAHOL) were among the most significant individual contributors to fund performance during the quarter (2.08% and 1.88% of total net assets, respectively.)Shire (LSE:SHP) is an Irish-based global specialty biopharmaceutical company. The company's stock price rose as it was the object of a takeover bid by a US drugmaker.Haci Omer Sabanci (IST:SAHOL) is a conservatively managed Turkish holding company, of which Akbank T.A.S. is the largest holding. During the second quarter, shares of Haci Omer Sabanci rebounded strongly from a deeply sold-off position at the end of the previous quarter. Improving senti! ment toward Turkey and emerging markets in general drove the stock's rally.Stock selection in the consumer discretionary sector was a key detractor from relative results. An underweight in consumer staples, a sector we still consider overvalued, hurt relative results as well. However, the consumer staples stocks the fund did hold outperformed the index sector.A higher-than-average cash position during the quarter was a drag on results.Balfour Beatty PLC (LSE:BBY) was one of the largest individual detractors from fund performance during the quarter (0.69% of total net assets). Balfour Beatty is a UL-based multi-national infrastructure company with interests in construction and support services and infrastructure investments. The company released a profit warning and announced the possible sale of its professional services business. The UK construction environment remains challenging, particularly for the most profitable large infrastructure projects. However, a rapid rise in construction margins from current low levels should lead to a significant rise in both earnings expectations and investor interest.Positioning and OutlookDuring the quarter, we continued to look for opportunities to improve the portfolio's growth potential and quality by adding and/or selling stocks based on the team's earnings, quality and valuation or EQV outlook for each company. As a result, we added two new holdings to the portfolio and sold four holdings.Additions to the portfolio were German multi-national sporting goods company Adidas AG (XTER:ADS) and UK-based global real estate services provider Savills PLC (LSE:SVS) (0.74% and 0.50% of total net assets, respectively).Weakening fundamentals led to the sale of Swiss multi-national food and beverage company Nestle SA (XSWX:NESN), German telecommunications company Deutsche Telekom AG (XTER:DTE), Belgium-based automobile distributor and services provider D'leteren SA (XBRU:DIE) and UK-based defense and countermeasures company Chemring Group PLC (LSE:CHG) (all 0.00% of t! otal net ! assets).From a broad market perspective, European valuation levels appear favorable relative to other regions but earnings have yet to see a normal recovery from the recession. Japan's correction so far this year has improved valuations, but critical structural reforms in Japan may prove to be elusive in the near term and quality opportunities remain scarce. Emerging markets began to show signs of stabilization, which has increased focus on the region, but most emerging market economics remain fragile, and economic recovery across the region is expected to be in consistent. In sum, we continue to believe that improvements in broad corporate and economic fundamentals are struggling to keep pace with rising expectations for economic acceleration in the second half of 2014.As always, regardless of the macroeconomic environment, we remain focused on our long-term, bottom-up investment approach to identify attractive companies that satisfy our EQV investment process.Continue reading here.Also check out: Invesco European Growth Fund Undervalued Stocks Invesco European Growth Fund Top Growth Companies Invesco European Growth Fund High Yield stocks, and Stocks that Invesco European Growth Fund keeps buying

Currently 0.00/512345

Rating: 0.0/5 (0 votes)

Subscribe via Email RSS Feeds

Subscribe RSS Comments Please leave your comment:
More GuruFocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool

5 Best Safest Stocks For 2014

European stocks have done well in 2013. The Vanguard FTSE Europe ETF and iShares Europe ETF may still be good bets.

NEW YORK (CNNMoney) Stocks are surging in the United States this year. Japan has done even better.

But if you're looking for the next big opportunity, Europe could very well be the best place to invest right now. The long recession in Europe may finally be over. And that could lead to stronger profits from European-based companies.

So what's the safest way to try and ride a European rebound?

Investing through a mutual fund: Many funds from big money managers have a fair amount of European exposure.

Take the widely held Fidelity Worldwide Fund (FWWFX), which has 30% of its assets invested in Europe. Holdings include Swiss bank UBS (UBS), German automaker Volkswagen (VLKAY) and French food and consumer products giant Danone (DANOY).

Hot Food Companies For 2015: Outerwall Inc (OUTR)

Outerwall Inc, formerly Coinstar, Inc., incorporated on October 12, 1993, is a provider of automated retail solutions, which offers convenient products and services. the Company's offerings in automated retail include its Redbox business, where consumers can rent or purchase movies and video games from self-service kiosks (Redbox segment), and its Coin business, where consumers can convert their coin to cash or stored value products at self-service coin counting kiosks (Coin segment). Its New Ventures business (New Ventures segment) is focused on identifying, evaluating, building, and developing self-service concepts in the marketplace. On June 9, 2011, the Company completed the sale transaction of the Money Transfer Business to Sigue Corporation (Sigue). In June 2012, the Company�� wholly owned subsidiary, Redbox Automated Retail, LLC, acquired certain assets of NCR Corp's self-service entertainment DVD kiosk business. In October 2013, Jana Partners LLC acquired a 13.5% stake in Outerwall Inc.

Redbox

Within the Company�� Redbox segment, it operates 35,400 Redbox kiosks, in 29,300 locations, where consumers can rent or purchase movies and video games. Its Redbox kiosks are available in every state, as well as Puerto Rico and are installed at grocery stores, mass retailers, drug stores, restaurants and convenience stores, including Walgreens, Walmart and McDonalds. Its Redbox kiosks supply the functionality of a traditional video rental store, which occupy an area of less than 10 square feet. Consumers use a touch screen to select their titles, swipe a valid credit or debit card, and receive their movie or video game. The daily rental fee at a Redbox kiosk is a flat fee plus tax for one daily rental and, if the consumer chooses to keep the movie or video game for additional days, the consumer is charged for each additional day at the same daily rental fee. Its consumers can rent a movie or video game from one location and return their rental to any of its Redbox locations.! In addition, its consumers may reserve a movie or video game online or through a smart phone application and pick it up at the selected Redbox location.

The Company generates revenue through fees charged to rent or purchase a movie or video game, and it pays retailers a percentage of its revenue. Its content library consists of movies and video games available for rent or purchase. It obtains its movie and video game content through revenue sharing agreements and license agreements with studios and game publishers, as well as through distributors and other suppliers.

Coin

As of December 31, 2011, within the Company�� Coin segment, it owned and operated approximately 20,200 coin-counting kiosks (approximately 17,200, of which offer a range of stored value products to consumers) in 19,900 locations, where consumers feed loose change into the kiosks, which count the change and then dispense vouchers or, in some cases, issue stored value products, at the consumer�� election. Its Coin kiosks are available across the United States, where they provide service to retailers, such as Kroger and Walmart, and in Canada, Puerto Rico, Ireland and the United Kingdom. It generates revenue through transaction fees from its consumers and product partners. Each voucher lists the dollar value of coins counted, less its transaction fee. When consumers elect to have a stored value product issued, the transaction fee normally charged to the consumer is charged instead to the card issuers for the coin-counting services.

New Ventures

Within the Company�� New Ventures segment, it identifies, evaluates, builds and develops self-service concepts in the automated retail space. Its New Ventures segment consists of its coffee, refurbished electronics and photo self-service concepts. It generates revenue through fees charged for products and services offered to consumers in select test markets where it is testing business concepts.

Advisors' Opinion:

[By CNNMoney Staff]
Shares of Outerwall Inc. (OUTR), which produces Redbox and Coinstar dispensers, surged 12% on news that the company plans to buy back $350 million worth of stock.
[By Rick Munarriz]
The kiosk operator began trading as Outerwall (NASDAQ: OUTR ) today, ringing the exchange's opening bell and announcing a significant acquisition.
[By Austin Smith]
The Motley Fool is on the road in Seattle!�Recently we visited Coinstar -- now officially renamed�Outerwall� (NASDAQ: OUTR ) --�to speak with CFO-turned-CEO Scott Di Valerio about the 22-year-old company's well-known coin-cashing machines, as well as its more recent acquisition of Redbox, and future initiatives to expand into other aspects of the automated retail market.
[By Austin Smith]
The Motley Fool is on the road in Seattle!�Recently we visited Coinstar -- now officially renamed�Outerwall� (NASDAQ: OUTR ) --�to speak with CFO-turned-CEO Scott Di Valerio about the 22-year-old company's well-known coin-cashing machines, as well as its more recent acquisition of Redbox, and future initiatives to expand into other aspects of the automated retail market.

5 Best Safest Stocks For 2014: Rostelekom OAO (ROSYY)

Rostelecom is a telecommunications services provider and carrier of domestic long distance (DLD) and international long distance (ILD) traffic in the Russian Federation. The Company owns and operates a trunk telecommunications network and carries the bulk of Russia's long-distance and international traffic. The Company renders domestic and international long-distance telecommunications services to end users and provides traffic throughput services to Russian operators, including each of Russia's seven inter-regional companies (IRCs) and alternative operators. In addition, the Company provides telecommunications services to various government entities across Russia and ensures the operation of the ground-based network of television and radio broadcasting channels. In December 2008, through Westelcom, its wholly owned subsidiary, Rostelecom acquired an additional 15.2% interest in CJSC Incom (Incom). Subsequently Incom became a wholly owned subsidiary of the Company. In December 2008, it sold 10.87% interest in CJSC Expo-Telecom.

In February 2008, the Company sold its 10.97% interest in Golden Telecom. In March 2008, the Company sold its 10.30% interest in OJSC AVIANET. In July 2008, Rostelecom acquired a 68.42% interest in OJSC RTComm.RU (RTComm.RU). In September 2008, the Company sold its 15% interest in CJSC Transportation Digital Networks.

The Company has entered into service contracts with the IRCs and other operators of local and intra-regional networks to act as its regional agents. In this capacity, the Company�� agents bill end users, prepare, print and deliver invoices and collect payments from end users and perform customer service functions. Its trunk network, which transmits a Russia's domestic and international long-distance traffic, comprises approximately 150,000 kilometers of digital and analog lines.

The Company�� primary network consists of trunk cables linked to the IRCs networks and to its international exchanges for connections with for! eign operators, as well as a satellite communications network. As of December 31, 2008, the Company�� digital network comprised 49,987 kilometers, including 35,291 kilometers of fiber optic lines (FOLs) and 14,696 kilometers of digital radio-relay lines.

As of December 31, 2008, the Company owned 13 international exchanges, which allow for ILD traffic management, including four in Moscow, two in St. Petersburg (Lyuban) and one each in Rostov-on-Don, Samara, Ekaterinburg, Novosibirsk, Khabarovsk, Kaliningrad and Murmansk. The combined capacity of these switches was 235,500 channels. In addition, the Company had 15 transit and six multi-transit domestic long-distance exchanges interconnected to its telecommunications network for traffic transit that provide access to DLD services to local users. The domestic long-distance exchanges and their connecting digital channels constitute an integrated services digital network (ISDN) with channel switches, to which the networks of IRCs and alternative operators are connected. The trunk exchanges of Moscow and Pavlov Posad route domestic long-distance traffic between switching centers, as well as directly to and from end users.

As of December 31, 2008, the Company�� domestic long-distance trunk network consisted of 675,300 digital and 900 analog channels. Rostelecom provides domestic and international ISDN services through 76 trunk exchanges. The Company has an open network of multimedia communications. Connected to this network are subscriber units in 76 Russian regions and 13 retail outlets.

Rostelecom�� main satellite communications network is operated by 16 nodal land-based stations located in Russia. The Company also operates a second satellite communications network, Reserv, which comprises one central and one periphery land-based station. To enable its operation, it leases channels from OJSC Gazcom, which operates earth satellite vehicle Yamal-200. The Company rents domestic and international fixed satellite chan! nels from! FSUE Space Communications, CJSC SatComLine, CJSC SvyazContactInform, OJSC YamalTelecom and CJSC Zond Holding, which are Russian satellite telecommunications companies that operate satellites in the FSUE Space Communications and Intelsat systems.

The Company competes with TransTelecom, Synterra, FSUE Space Communications, TeliaSonera and Golden Telecom.

Advisors' Opinion:

[By Halia Pavliva]
The Bloomberg Russia-US gauge slipped 0.4 percent to 104.16, paring its advance this month to 7.7 percent. CTC Media Inc. (CTCM), the Nasdaq-listed Russian television company, rallied 2.6 percent to $12.86, the highest level since April 25. The stock has climbed 22 percent this month, making it the best performer on the Bloomberg-Russia gauge. VimpelCom is the second-biggest gainer on the index this month, followed by OAO Rostelecom (ROSYY), which has increased 17 percent after two months of declines.

5 Best Safest Stocks For 2014: Taubman Centers Inc (TCO)

Taubman Centers, Inc. (TCO), incorporated November 21, 1973, operates as a self-administered and self-managed real estate investment trust (REIT). The Taubman Realty Group Limited Partnership (TRG) is a subsidiary of TCO that owns direct or indirect interests in all of its real estate properties. The Company owns, leases, acquires, disposes of, develops, expands and manages regional and super-regional shopping centers and interests therein. As of December 31, 2012, the Company owned a portfolio of 24 urban and suburban shopping centers in 12 states. The consolidated Businesses consist of shopping centers and entities that are controlled by ownership or contractual agreements, The Taubman Company LLC (Manager), and Taubman Properties Asia LLC and its subsidiaries (Taubman Asia). In December 2012, it acquired additional 49.9% (100% in total) interest in International Plaza, located in Tampa, Florida. Also in December 2012, it acquired additional 25% (50% in total) interest in Waterside Shops. In January 2014, Taubman Centers Inc announced the completion of the sale of land owned by Taubman in Syosset, New York, and Taubman's interest in Arizona Mills to Simon Property Group.

The Company�� centers are located in metropolitan areas, including Charlotte, Dallas, Denver, Detroit, Los Angeles, Miami, Nashville, New York City, Orlando, Phoenix, San Francisco, Tampa, and Washington, D.C. The centers range in size between 236,000 and 1.6 million square feet of gross leasable area (GLA) and between 186,000 and 646,000 square feet of Mall GLA. Of the 24 centers, 18 are super-regional shopping centers. The Company�� centers have approximately 3,000 stores operated by their mall tenants under approximately 850 trade names. The centers have 65 anchors, operating under 14 trade names. The centers lease over 95% of leased Mall GLA to national chains, including subsidiaries or divisions of Forever 21 (Forever 21, For Love 21, XXI Forever, and others), The Gap (Gap, Gap Kids, Baby Gap, Banana Republic, ! Old Navy, and others), and Limited Brands (Bath & Body Works/White Barn Candle, Pink, Victoria's Secret, and others).

Advisors' Opinion:

[By Rich Duprey]
Shopping-mall operator�Taubman Centers� (NYSE: TCO ) �announced yesterday�its second-quarter dividend of $0.50 per share, the same rate it paid last quarter after raising the payout 8%, from $0.4625 per share.

5 Best Safest Stocks For 2014: Texas Capital Bancshares Inc.(TCBI)

Texas Capital Bancshares, Inc. operates as the holding company for Texas Capital Bank, National Association that provides various banking products and services for commercial and high net worth customers in Texas. It primarily engages in generating deposits and originating loans. The company?s deposit products include consumer checking accounts, savings accounts, money market accounts, and certificates of deposit, as well as commercial checking accounts, lockbox accounts, cash concentration accounts, and other treasury management products. Its lending products portfolio comprises commercial loans and leases; real estate loans, including loans secured by properties, and temporary financing for commercial and residential property; construction loans consisting of single-family residential properties and commercial projects; loans held for sale; and letters of credit. The company also provides trust and wealth management services, including investment management, personal tr ust and estate services, custodial services, retirement accounts, and related services, as well as offers retirement products, including individual retirement accounts and administrative services for retirement vehicles, such as pension and profit sharing plans. Texas Capital Bancshares, Inc. has banking offices in Dallas, Houston, Fort Worth, Austin, San Antonio, and the Cayman Islands. As of December 31, 2010, it conducted business at nine full service banking locations and one operations center. The company was founded in 1996 and is headquartered in Dallas, Texas.

Advisors' Opinion:

[By Charley Blaine]
Also in the list: Bank of America (NYSE: BAC), up 13.31 percent; Citigroup (NYSE: C), up 8.8 percent; U.S. Bancorp (NYSE: USB), up 5.33 percent; and Texas Capital Bancshares (NASDAQ: TCBI) up 8.18 percent.

Monday, July 28, 2014

Top Medical Stocks To Invest In 2014

John McCamant, biotech expert and editor of The Medical Technology Stock Letter, believes this company offers one of the most intriguing pipelines in the cancer treatment sector.

Incyte Pharmaceuticals (INCY) recently held their quarterly conference call. Importantly, sales for Jakafi��n advanced compound used for the treatment of patients with intermediate or high-risk myelofibrosis (MF)��et or exceeded Wall Street's expectations.

The company provided solid guidance for Jakafi in 2014 of $315-$335 million, which reflects year-over-year growth of 34%-42%, driven by new patient starts, continued improvement in physician education, and persistency.

Of interest, INCY's guidance assumes no meaningful contribution from a Jakafi approval in polycythemia vera (PV), which could occur before yearend. PV is a type of blood cancer.

We remain excited about the PV opportunity for Jakafi, as market research shows an addressable PV patient population that is larger than MF, and PV patients are expected to stay on the drug longer than MF patients.

Best Oil Stocks To Watch Right Now: Hemispherx Biopharma Inc (HEB)

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.The commercial focus for Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as an influenza vaccine enhancer (adjuvant) for both therapeutic and preventative vaccine development. Alferon N Injection is a United States Food and Drug Administration (FDA) approved product with an indication for refractory or recurring genital warts. Alferon LDO (Low Dose Oral) is a formulation under development targeting influenza. It has three subsidiaries BioPro Corp., BioAegean Corp., and Core BioTech Corp. The Company's foreign subsidiary is Hemispherx Biopharma Europe N.V./S.A.

Ampligen

Ampligen is an experimental drug, which is undergoing clinical development for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Over 1,000 patients have participated in the Ampligen clinical trials representing the administration of more than 90,000 doses of this drug. The Company is also engaged in ongoing, experimental studies assessing the efficacy of Ampligen against influenza viruses.

Alferon N Injection

Alferon N Injection is the registered trademark for the Company's injectable formulation of natural alpha interferon. Interferons are a group of proteins produced and secreted by cells to combat diseases. The Company's natural alpha interferon is produced from human white blood cells. Alferon N Injection [Interferon alfa-n3 (human leukocyte derived)] is a highly purified, natural-source, glycosylated, multi-species alpha interferon product.

Alferon LDO (Low Dose Oral)

Alferon LDO [Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)]! is an experimental low-dose, oral liquid formulation of Natural Alpha Interferon and like Alferon N Injection should not cause antibody formation, which is a problem with recombinant interferon. It is an experimental immunotherapeutic that works by stimulating an immune cascade response in the cells of the mouth and throat, enabling it to bolster systemic immune response through the entire body by absorption through the oral mucosa.

The Company competes with Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Baxter International, Fletcher/CSI, AVANT Immunotherapeutics, AVI BioPharma and Genta.

Advisors' Opinion:

[By MONEYMORNING]
Hemispherix Biopharma Inc. (NYSE: HEB) is a specialty pharmaceutical company. It engages in the clinical development of new drug therapies based on natural immune system enhancing technologies and targets the treatment of viral and immune-based clinical disorders. The Philadelphia, Pa.-headquartered company gained widespread attention over the last several months for its work on flu research. Its flagship products include Alferon N Injection, approved by the FDA for a category of sexually transmitted disease infection. Experimental treatments include Ampligen and Oragens, in development stages for the potential treatment of global viral diseases and disorders of the immune system including human papilloma virus, human immunodeficiency virus, chronic fatigue syndrome, hepatitis, and influenza. Shares have traded as low as $0.18 and as high as $0.55 over the last year. At last check, shares were changing hands around $0.50 on volume of 2 million shares.

Top Medical Stocks To Invest In 2014: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:

[By John Udovich]
Recent news surrounding small cap biotech stocks like�Xencor Inc (NASDAQ: XNCR), Prosensa Holding NV (NASDAQ: RNA),�Puma Biotechnology Inc (NYSE: PBYI),�Geron Corporation (NASDAQ: GERN)
and TNI BioTech Inc (OTCQB: TNIB) show that while the sector and appetite for biotech�IPOs may have cooled, lottery tickets can still be found or occur in the sector. Just consider the following recent news or trends:
[By Bryan Murphy]
Anybody who knows at least something about Prosensa Holding NV (NASDAQ:RNA) will at least know the stock turned into a disaster a few weeks ago, plunging from a close of $24.00 on September 19th to a close of $7.14 on September 20th, thanks to the failure of its MS drug drisapersen, which was jointly developed with GlaxoSmithKline plc (NYSE:GSK). Such is the life of a company with only one drug anywhere close to being approved; drisapersen was in Phase 3 trials - RNA shares could have just as easily gained 70% rather than lost 70% had the drug worked.

Top Medical Stocks To Invest In 2014: CareFusion Corp (CFN)

CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�� Medical Systems segment�� business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�� disposable products and reusable surgical instruments businesses. The Company�� Procedural Solutions segment�� business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Medical Systems Segment

The Company�� develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy inf! ormation and electronic medical records.

The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers��utilization of its medical equipment products. The Company�� project management, field service organization and customer call centers support its customers before, during and after product installation. The Company�� project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company�� field service organization provides on-site expertise to resolve customers��service issues. The Company�� customer call centers provide additional support to its customers.

The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient�� veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.

The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.

Procedural Solutions Segment

The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segm! ent are u! sed in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.

The Company�� Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company�� Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company�� Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.

The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.

Advisors' Opinion:

[By Sean Williams]
Heading notably higher as well, up 5.5%, was medical-products supplier CareFusion (NYSE: CFN ) which is said to be in talks as a possible acquirer of Britain-based Smiths Group's medical division. Although neither company would comment on a potential sale it would clearly be a positive for CareFusion since its revenue growth has stagnated in recent years. We should hopefully know more about these developments over the coming weeks.

Top Medical Stocks To Invest In 2014: Guided Therapeutics Inc (GTHP)

Guided Therapeutics, Inc., incorporated on October 27, 1992, is a medical technology company focused on developing medical devices. The Company�� primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.

The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions. The product is expected to incorporate a single-use, disposable calibration and alignment component.

The Company competes with Qiagen, MediSpectra, Inc., Merck & Co., Inc., and GlaxoSmithKline PLC.

Advisors' Opinion:

[By CRWE]
Today, GTHP remains (0.00%) +0.000 at $.710 with 44,700 shares in play thus far (ref. google finance Delayed: 11:42AM EDT August 21, 2013).

Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.

Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.
[By CRWE]
Last Friday, GTHP had shed (-2.16%) down -0.015 at $.679 with 39,538 shares in play at the close (ref. google finance August 23, 2013 ��Close).

Guided Therapeutics, Inc. previously reported its operating results for the second quarter and six months ended June 30, 2013.

Revenue and other income for the second quarter of 2013 was approximately $338,000, including $116,000 in sales of LuViva庐 devices and disposables associated with its European launch, with the remainder of revenue representing contract and grant income. This compares to revenue of approximately $944,000 in the second quarter of 2012, which was comprised almost solely of contract and grant income. Revenue for the first six months of 2013 was $637,000, including $248,000 in sales of LuViva device and disposables. Revenue in the first six months of 2012 was $1.6 million, which was comprised almost solely of contract and grant income. The year over year decline in contract and grant income for both periods was primarily due to bringing the worldwide rights to the Company�� esophageal cancer detection technology back in house.

Sunday, July 27, 2014

Top 5 Growth Stocks To Own For 2014

The following video is from Tuesday's MarketFoolery podcast, in which host Chris Hill and analysts Matt Argersinger and Jason Moser discuss the top business and investing stories of the day.

Shares of Netflix (NASDAQ: NFLX ) �soared on Tuesday in the wake of better-than-expected earnings. Netflix announced that it added 2 million new U.S. customers in the first three months of 2013. Netflix CEO Reed Hastings attributed the company's succes to the "halo effect" from the Netflix original series House of Cards.

Will Netflix continue to find success with original programming? Will Netflix need to raise prices as it expands its original programming? To what extent can Amazon.com (NASDAQ: AMZN ) slow Netflix's growth? Should investors buy Netflix? In this installment of MarketFoolery, our analysts discuss the future of Netflix.

The relevant video segment can be found between 1:16 and 10:24.

The tumultuous performance of Netflix shares since the summer of 2011 has caused headaches for many devoted shareholders. While the company's first-mover status is often viewed as a competitive advantage, the opportunities in streaming media have brought some new, deep-pocketed rivals looking for their piece of a growing pie. Can Netflix fend off this burgeoning competition, and will its international growth aspirations really pay off? These are must-know issues for investors, which is why The Motley Fool has released a premium report on Netflix. Inside, you'll learn about the key opportunities and risks facing the company, as well as reasons to buy or sell the stock. The report includes a full year of updates to cover critical new developments, so make sure to click here and claim a copy today.

Hot China Companies To Invest In Right Now: Crocs Inc.(CROX)

Crocs, Inc. and its subsidiaries engage in the design, development, manufacture, marketing, and distribution of footwear, apparel, and accessories for men, women, and children. The company primarily offers casual and athletic shoes, and shoe charms. It also designs and sells a range of footwear and accessories that utilize its proprietary closed cell-resin, called Croslite. The company?s footwear products include boots, sandals, sneakers, mules, and flats. In addition, it provides footwear products for the hospital, restaurant, hotel, and hospitality markets, as well as general foot care and diabetic-needs markets. Further, the company offers leather and ethylene vinyl acetate based footwear, sandals, and printed apparels principally for the beach, adventure, and action sports markets; and accessories comprising snap-on charms. The company sells its products through the United States and international retailers and distributors, as well as directly to end-user consumers th rough its company-operated retail stores, outlets, kiosks, and Web stores primarily under the Crocs Work, Crocs Rx, Jibbitz, Ocean Minded, and YOU by Crocs brand names. As of December 31, 2010, it operated 164 retail kiosks located in malls and other high foot traffic areas; 138 retail stores; 76 outlet stores; and 46 Web stores. Crocs, Inc. operates in the Americas, Europe, and Asia. The company was formerly known as Western Brands, LLC and changed its name to Crocs, Inc. in January 2005. Crocs, Inc. was founded in 1999 and is headquartered in Niwot, Colorado.

Advisors' Opinion:

[By Eric Volkman]
Getty Images/Scott Olson The demise of Crocs (CROX), it seems, may have been greatly exaggerated. Remember the company's signature product? Close to a decade ago, those colorful, clunky resin clogs were all the rage. The company that made them couldn't sell the things fast enough, at one point reaching sales of 50 million pairs in 2007. Then fashion moved on, as it always does, and the economic slowdown started to bite into sales. Crocs plunged from a $168 million net profit in 2007 to a $185 million loss in 2008. In 2009, the company nearly ran out of cash and had a hard time making payroll. But Crocs' fortunes have improved. In its most recent quarter, the firm posted a loss, but it was narrower than the market was expecting. And it's found an investor that believes in its future -- private equity giant Blackstone Group (BX), which recently provided a $200 million cash investment in return for a block of preferred shares eventually convertible into a stake of around 13 percent of the company. Perhaps the time has come to take those old clogs out of the closet, dust them off, and slip them on for a stroll. Stepping It Up Fashion is highly susceptible to consumer whim. The hot item is never hot for very long, and once consumers move on, it can be hard for the company to recover. In Crocs' case, this was exacerbated by its limited product line -- almost exclusively the clogs. The company learned from its mistakes. Since consumer tastes moved out of clog-land, Crocs has significantly broadened its product line to 300 styles. It now offers boots, flip-flops, deck shoes and slip-ons akin to the casuals from VF Corp.'s (VFC) Vans subsidiary. In terms of profitability, Crocs recovered quickly from its time in the fashion wilderness. From that 2008 bottom-line deficit of $185 million, the company sliced its loss to $42 million the following year, then stepped back into the black in 2010 (to the tune of $68 million). After two straight years of declines, revenue

Top 5 Growth Stocks To Own For 2014: Thoratec Corporation(THOR)

Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The company?s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge, and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising hom e discharge, and post-cardiotomy myocardial recovery. The company also provides CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure. In addition, it offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. The company sells its products through direct sales force in the United States, as well as through a network of distributors internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

Advisors' Opinion:

[By Todd Campbell]
Competing for heart pump market share
Abiomed's products provide circulatory support for up to six hours and are designed for use in cardiac cath labs or during heart surgery, but competitors Thoratec (NASDAQ: THOR ) and Heartware (NASDAQ: HTWR ) target the intermediate- and long-term-use market instead.

Top 5 Growth Stocks To Own For 2014: Nordstrom Inc.(JWN)

Advisors' Opinion:

[By Peter Graham]
The Q1 2014 earnings report for troubled J.C. Penney Company, Inc (NYSE: JCP), a peer of other department store stocks like Kohl's Corporation (NYSE: KSS), The Bon-Ton Stores, Inc (NASDAQ: BONT) and Nordstrom, Inc (NYSE: JWN), is scheduled for after the market closes on Thursday. Aside from the J.C. Penney Company's earnings report, it should be said that�Kohl's Corporation will report Q1 2014 when the market opens on Thursday; Nordstrom will report earnings after the market closes on Thursday; and The Bon-Ton Stores will report Q1 2014 earnings on Thursday, May 22nd before the market opens. However, all eyes will be on the J.C. Penney Company earnings report to see if there are any signs the company has turned itself around from the ill-fated�leadership of CEO Ron Johnson��who ironically was also trying to turn things around��/p>
[By Ben Levisohn]
[Sears Canada is also] seeing or about to see a wave of fresh competition from Wal-Mart Stores (WMT) and Target’s (TGT) recent northern expansions to Nordstrom’s (JWN) upcoming launch. The company still operates 24.8 million square feet of retail space, but only 14 full-line department stores are company-owned and as we mentioned above, much of the best real estate has been sold. Yes, Sears Canada has a net cash position, but we expect Sears Holdings to take as much cash as they can beforehand in the event of any sale or spin-off.

Top 5 Growth Stocks To Own For 2014: Eastern Insurance Holdings Inc.(EIHI)

Eastern Insurance Holdings, Inc., through its subsidiaries, provides workers compensation insurance and reinsurance products in the United States. The company?s Workers Compensation Insurance segment provides traditional workers compensation insurance coverage products, including guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies, deductible policies, and alternative market products to employers. This segment distributes its workers? compensation products and services through its independent insurance agents primarily in Pennsylvania, Delaware, North Carolina, Maryland, Indiana, and Virginia. Its Segregated Portfolio Cell Reinsurance segment offers alternative market workers compensation solutions comprising program design, fronting, claims administration, risk management, segregated portfolio cell rental, asset management, and segregated portfolio management services to individual companies, groups, and associations. Eastern Insurance Holdings, Inc. is headquartered in Lancaster, Pennsylvania.

Advisors' Opinion:

[By Lauren Pollock]
ProAssurance Corp.(PRA) agreed to acquire Eastern Insurance Holdings Inc.(EIHI) for about $205 million, expanding the insurance company’s casualty insurance offerings. Eastern Insurance is a domestic casualty insurance group specializing in workers’ compensation products and services, among other things. ProAssurance plans to pay $24.50 in cash for each outstanding Eastern share, a 16% premium over Monday’s closing price.

5 Best Blue Chip Stocks To Buy Right Now

5 Best Blue Chip Stocks To Buy Right Now: McDonald's Corporation(MCD)

McDonald?s Corporation, together with its subsidiaries, operates as a worldwide foodservice retailer. It franchises and operates McDonald?s restaurants that offer various food items, soft drinks, coffee, and other beverages. As of December 31, 2009, the company operated 32,478 restaurants in 117 countries, of which 26,216 were operated by franchisees; and 6,262 were operated by the company. McDonald?s Corporation was founded in 1948 and is based in Oak Brook, Illinois.

Advisors' Opinion:

[By Alyssa Oursler]
When investors looks for dividends, they often opt for venerable blue-chips like Verizon (VZ), Procter & Gamble (PG) or McDonald’s (MCD). But it’s important to remember that size — or the size of the company, that is — isn’t everything.
[By Editor , Dividend Growth Investor]
McDonald’s (MCD)has boosted distributions for 38 years in a row. The company has managed to increase dividends by 22.80%/year over the past decade.Yield: 3.40% (analysis)
[By Dividends4Life]
Over the few years, I have reduced my bond allocation and purchased quality blue-chip dividend stocks that are yielding in excess of my bond holdings. Consider these dividend growth stocks that have a current yield equal to or greater than the May 30, 2014, 3.12% yield on 20-year U.S. Treasuries.McDonald's Corp(MCD) is the largest fast-food restaurant company in the world, with nearly 35,000 restaurants in 119 countries. Yield: 3.2%The Clorox Company (CLX) is a diversified producer of household cleaning, grocery and specialty food products is also a leading producer of natural personal care products. Yield: 3.3%Lockheed Martin Corp. (LMT) , the world's largest military weapons manufacturer, is also a significant supplier to NASA and other non-defense government agencies. LMT receives about 93% of its revenues from global defense sales. 3.3! %ConocoPhillips Co. (COP) is one of the largest independent oil and gas exploration and production (E&P) companies in the world, C OP spun off its downstream assets in May 2012. Yield: 3.5%Verizon Communications Inc. (VZ) is the largest U.S. wireless carrier, Verizon also offers wireline and broadband services primarily in the northeastern U.S. Yield: 4.2%AT&T Inc. (T) provides telephone and broadband service and holds full ownership of AT&T Mobility (formerly Cingular Wireless). Yield: 5.2% I am not predicting an imminent collapse of bond prices. As an investor (not a trader), I am not in the prediction business. However, I believe we have reached a point where there is much more to lose than gain by holding bonds. Interest rates will eventually rise and those holding bonds, especially long-term bonds, will suffer painful consequences.Full Disclosure: Long MCD, LMT, COP, T in my Dividend Growth Portfolio and long T in my High-Yield portfolio. See a list of all my dividend growth holdings hereRelated Articles - 6 Stocks With a Sustainable Dividend - 5 Dividend Stocks Building A Growing Cash Stream - 9 Dividend Stoc

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/5-best-blue-chip-stocks-to-buy-right-now-4.html

Saturday, July 26, 2014

Hot Biotech Companies To Watch For 2015

Hot Biotech Companies To Watch For 2015: Regeneron Pharmaceuticals Inc.(REGN)

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.

Advisors' Opinion:

[By Cynthia Andrade]
Looking at the portfolio, 55% of assets are in large-caps, 25% in mid-caps and the re! mainder in small firms. The fund has 56% of assets in its top ten holdings, which include Biogen (BIIB), Gilead (GILD), Amgen (AMGN), Regeneron (REGN), and Celgene (CELG).
[By Grace L. Williams]
Youd hardly know biotech Regeneron Pharmaceuticals (REGN) reported a mixed first quarter this morning. Although the stock is down now, shares popped earlier, trading up as much as 1.8% around 10:30 a.m. before simmering down.

For the period ended March 31, Regeneron reported earnings of $2.26 a share or $263 million, up from $1.78 or $201 million year-over-year. Revenue rose to $626 million compared to $440 million. Analysts polled by Thomson Reuters most recently forecast earnings of $2.20 a share, on sales of $610 million. The big downer: Disappointing sales of Regeneron’s eye treatment, Eylea.

Citigroup analyst Yaron Werber, however, calls the weak sales a temporary setback and considers weakness in Regeneron a buying opportunity. He explains why:

Eylea sales were a miss at $356 million versus our $409 million and Consensus $404 million, impacted by a decrease in distributor inventory and typically weak first quarter. Unit demand for Eylea grew by 25% year-over-year excluding inventory. The guidance was re-affirmed and we expect sales to bounce back in the second quarter and benefit from DME approval in the third quarter of 2014…This quarter was anticipated to be weak and any weakness in the stock provides an entry point ahead of a robust year of data for Alirocumab and dupilumab, ongoing strong ex-US launch of Eylea and expected approval in DME in the US by August 18th.

Shares of Regeneron have dropped 1.7% to $281.81 at 3:116 p.m. The iShares Nasdaq Biotechnology ETF (IBB) has fallen 2% to $222.94, while the SPDR S&P Biotech ETF (XBI) has slid 3.8% to $120.
[By Sean Williams]
The lead drug
This is actually the most difficult choice because there are so many top-performing lead drug candidates. In deciding ! which one! to choose I focused on a mixture of total sales potential, time until patent expiration, as well as the potential for indication expansion. I narrowed it down to two lead drug candidates: Celgene's (NASDAQ: CELG ) Revlimid and Regeneron Pharmaceuticals' (NASDAQ: REGN ) Eylea.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-biotech-companies-to-watch-for-2015-2.html